Close Menu

microarrays

NEW YORK (GenomeWeb) – The agricultural biotechnology and non-invasive prenatal testing markets could become significant revenues drivers for Affymetrix, company officials said this week after the firm released its third quarter financial results.

To better understand the relationship between sea lice populations at salmon farms across the North Atlantic, as well as to identify genomic regions that could potentially shed light on pesticide resistance, researchers recently designed a 6,000-SNP genotyping microarray focused on Lepeophtheirus salmonis, the salmon louse.

General Electric has been awarded

NEW YORK (GenomeWeb) – Agilent Technologies said on Monday that Genetic Technologies has dismissed its lawsuit against the company alleging patent infringement.

NEW YORK (GenomeWeb) – Affymetrix's third quarter revenues increased 8 percent year over year, the company reported after the close of the market on Thursday.

NEW YORK (GenomeWeb) — Fluidigm said after the close of the market on Thursday that its third quarter revenues increased 62 percent year over year, or 35 percent organically.

NEW YORK (GenomeWeb) – Two new Nature studies by independent research groups catalogued and characterized the role that rare, protein-coding mutations or variants play in autism spectrum disorder.

NEW YORK (GenomeWeb) – Researchers from the Broad Institute, Massachusetts General Hospital, Yale School of Medicine, and elsewhere have used a combination of genetic, gene expression, and epigenetic marker information to map the causal variants contributing to 21 inflammatory autoimmune conditio

NEW YORK (GenomeWeb) — Scienion and Genomica today announced the CE IVD marking and launch of their jointly developed multiplex molecular assay for sexually transmitted infections.

NEW YORK (GenomeWeb) — Oxford Gene Technology this week said it will initiate a clinical trial of a new, microarray-based non-invasive prenatal test for Down's syndrome.

Pages

NPR reports that graduate students in the US are helping with SARS-CoV-2 testing.

Politico reports President Donald Trump has signed the $2 trillion coronavirus relief package.

A new analysis finds that peer review improves the quality of preprints just a little bit, according to ScienceInsider.

In PLOS this week: epigenetic drug triggers anti-viral activity, viral diversity among individuals with HIV experiencing virological failure, and more.